The Coalition for the Advancement of Medical Research (CAMR) is the nation's leading bipartisan pro-cures coalition. Comprised of 100 nationally recognized patient organizations, universities, scientific societies, and foundations, CAMR’s advocacy and education outreach focuses on research toward developing better treatments and cures for individuals with life-threatening illnesses and disorders.
On March 9, 2009, President Obama signed an Executive Order calling for federal funding and NIH oversight of embryonic stem cell research. The NIH released its guidelines for funding and oversight on July 6, 2009, and stem cell lines have already been approved for research and funding. However, there is still work to be done. We anticipate ongoing legislative and other challenges in the field of regenerative medicine as the research continues to move forward.
More than 100 million Americans suffer from cancer, Alzheimer's, diabetes, Parkinson's, spinal cord injuries, heart disease, ALS, and other debilitating diseases and disorders for which embryonic stem cell research provides great promise. CAMR is dedicated to being a national, collective voice on Capitol Hill and in the media for those who believe that regenerative medicine, including embryonic stem cell research, holds the key to providing American families with hope for the future.
To learn more about CAMR and what we do, as well as find some basic background information on stem cell research, check out the Who We Are section of this site. We hope you'll continue to check this site for ongoing legislative developments.
Click here for more information about judicial activity regarding embryonic stem cell research.
To read CAMR's white paper, Catalyst for Cures: Embryonic Stem Cell Research, click here